The DOI matches its Crossref record; 223 of the 223 references it cites were found in a registry or an index.
Microbial Translocation Across the GI Tract
Open accessAbstract
The lumen of the gastrointestinal (GI) tract is home to an enormous quantity of different bacterial species, our microbiota, that thrive in an often symbiotic relationship with the host. Given that the healthy host must regulate contact between the microbiota and its immune system to avoid overwhelming systemic immune activation, humans have evolved several mechanisms to attenuate systemic microbial translocation (MT) and its consequences. However, several diseases are associated with the failure of one or more of these mechanisms, with consequent immune activation and deleterious effects on health. Here, we discuss the mechanisms underlying MT, diseases associated with MT, and therapeutic interventions that aim to decrease it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, in the absence of infection, endotoxin still crosses the mucosal membranes of gut, gums, nose or lungs, the main source being intestinal permeability [36, 37].”
From The endotoxin hypothesis of neurodegeneration (2019) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444 · cited 2×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundA core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823 · cited 1×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundMizgerd, J. P., Kubo, H., Kutkoski, G. J., Bhagwan, S. D., Scharffetter-Kochanek, K., Beaudet, A. L., & Doerschuk, C. M. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1357 · Cited by 7,332
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S., & Medzhitov, R. (2004) · Cell · doi:10.1016/j.cell.2004.07.002 · Cited by 4,251 · cited 1×
“Consistent with this premise, decreased epithelial cell proliferation is observed in TLRdeficient mice (9).”
BackgroundThe Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,134 · cited 2×
“Although these trigger beneficial inflammatory responses to confine the infection and tissue damage, their excessive production results in elevated systemic inflammatory responses that may be more lethal than the bacterial infection itself (30).”
BackgroundMicrobial translocation is a cause of systemic immune activation in chronic HIV infection
Brenchley, J. M., Price, D. A., Schacker, T. W., Asher, T. E., Silvestri, G., Rao, S., Kazzaz, Z., Bornstein, E., Lambotte, O., Altmann, D., et al. (2006) · Nature Medicine · doi:10.1038/nm1511 · Cited by 3,559
Self-citationChen, L., Li, N., & Ye, H. (2012) · Hepatogastroenterology · doi:10.5754/hge12469 · Cited by 3,208
Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 2×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundTurnbaugh, P. J., Bäckhed, F., Fulton, L., & Gordon, J. I. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.02.015 · Cited by 2,915 · cited 1×
“This approach has shown, for example, that microbiota from obese mice, transferred to germ-free animals, appears to cause the germ-free animals to gain significant weight (28).”
BackgroundThe gut flora as a forgotten organ
O'Hara, A. M., & Shanahan, F. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400731 · Cited by 2,791 · cited 1×
“The beneficial roles that the GI microbiota play are multifactorial and may be separated into immunological, structural, and metabolic functions (4).”
BackgroundFord, R. C., & Eisenberg, S. (1990) · Nursing Clinics of North America · doi:10.1016/s0029-6465(22)02934-6 · Cited by 2,736
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,371
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330 · cited 1×
“Several therapeutic interventions aim to improve enterocyte homeostasis by the administration of cytokines such as IL-22, which is critical for maintenance of the structural barrier, particularly in the event of tissue damage (77, 85, 90, 211).”
BackgroundPhenotypic and functional features of human Th17 cells
Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E., Filì, L., Ferri, S., Frosali, F., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070663 · Cited by 1,861
Brenchley, J. M., Schacker, T. W., Ruff, L. E., Price, D. A., Taylor, J. H., Beilman, G. J., Nguyen, P. L., Khoruts, A., Larson, M. C., Haase, A. T., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040874 · Cited by 1,836
Self-citationSurface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
Induction of Protective IgA by Intestinal Dendritic Cells Carrying Commensal Bacteria
Macpherson, A. J., & Uhr, T. (2004) · Science · doi:10.1126/science.1091334 · Cited by 1,584 · cited 1×
“Secretory IgA thus serves as a line of defense against MT by limiting adhesion and entry into the epithelium, thereby facilitating clearance via the fecal stream (13, 14).”
BackgroundSellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483 · cited 1×
“Additionally, altered composition of the GI tract microbiota has also been suggested to play a role in IBD pathogenesis (99, 100), as revealed by mouse models of IBD in which inflammation is significantly reduced when the mice are housed in germ-free conditions (101, 102).”
BackgroundReceptor-Dependent Mechanisms of Cell Stimulation by Bacterial Endotoxin
Ulevitch, R. J., & Tobias, P. S. (1995) · Annual Review of Immunology · doi:10.1146/annurev.iy.13.040195.002253 · Cited by 1,442 · cited 1×
“LBP, in contrast, is an acute phase reactant produced by hepatocytes (51).”
BackgroundIL-22 Increases the Innate Immunity of Tissues
Wolk, K., Kunz, S., Witte, E., Friedrich, M., Asadullah, K., & Sabat, R. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.007 · Cited by 1,406 · cited 2×
“Several therapeutic interventions aim to improve enterocyte homeostasis by the administration of cytokines such as IL-22, which is critical for maintenance of the structural barrier, particularly in the event of tissue damage (77, 85, 90, 211).”
BackgroundVeazey, R. S., DeMaria, M. A., Chalifoux, L. V., Shvetz, D. E., Pauley, D. R., Knight, H., Rosenzweig, M., Johnson, R. P., Desrosiers, R. C., & Lackner, A. A. (1998) · Science · doi:10.1126/science.280.5362.427 · Cited by 1,404
Abreu, M. T. (2010) · Nature Reviews Immunology · doi:10.1038/nri2707 · Cited by 1,288
Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
Mattapallil, J. J., Douek, D. C., Hill, B. J., Nishimura, Y., Martin, M. A., & Roederer, M. (2005) · Nature · doi:10.1038/nature03501 · Cited by 1,269
Self-citationIL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia
Aujla, S. J., Chan, Y. R., Zheng, M., Fei, M., Askew, D. J., Pociask, D. A., Reinhart, T. A., McAllister, F. M., Edeal, J., Gaus, K., et al. (2008) · Nature Medicine · doi:10.1038/nm1710 · Cited by 1,219
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Self-citationMehandru, S., Poles, M. A., Tenner‐Racz, K., Horowitz, A., Hurley, A., Hogan, C., Boden, D., Rácz, P., & Markowitz, M. H. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041196 · Cited by 1,133
. Plasma levels of soluble CD14 independently predict mortality in HIV infection.
Sandler, N. G., Wand, H., Roque, A., Law, M., Nason, M. C., Nixon, D. E., Pedersen, C., Ruxrungtham, K., Lewin, S. R., Emery, S., et al. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq118 · Cited by 1,106
Self-citationI nterleukin -10 and R elated C ytokines and R eceptors
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., & Fisher, P. B. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104622 · Cited by 1,097 · cited 1×
“IL-22 belongs to the IL-10 family of cytokines (88), and its receptor is expressed on various epithelial tissues (89) and is believed to mediate epithelial innate immunity (90).”
BackgroundIL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis
Sugimoto, K., Ogawa, A., Mizoguchi, E., Shimomura, Y., Andoh, A., Bhan, A. K., Blumberg, R. S., Xavier, R. J., & Mizoguchi, A. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33194 · Cited by 1,059
Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coli
Ziegler, E. J., McCutchan, J. A., Fierer, J., Glauser, M. P., SADOFF, J. C., Douglas, H., & Braude, A. I. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211113072001 · Cited by 1,044
STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing
Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H.-A., Hirth, S., Weigmann, B., Wirtz, S., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082683 · Cited by 1,043 · cited 2×
“Therefore, though such studies suggest that IL-22 production by iLCs is critical for innate immunity in the intestine, the role of these cells in maintenance of the GI tract in the absence of infections is unclear given the relatively healthy structural barrier observed in IL-22-deficient mice (91) and the apparent ov…”
BackgroundGiorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B. M., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,032
Kelly, D., Campbell, J. I., King, T. P., Grant, G., Jansson, E. Å., Coutts, A., Pettersson, S., & Conway, S. (2003) · Nature Immunology · doi:10.1038/ni1018 · Cited by 1,026
Migueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D. H., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Smythies, L. E., Sellers, M. T., Clements, R. H., Mosteller‐Barnum, M., Meng, G., Benjamin, W. H., Orenstein, J. M., & Smith, P. D. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200519229 · Cited by 954
Li, Z., Yang, S., Lin, H., Huang, J., Watkins, P. A., Moser, A. B., Desimone, C., Song, X.-Y., & Diehl, A. M. (2003) · Hepatology · doi:10.1053/jhep.2003.50048 · Cited by 930
Bacterial contamination of pancreatic necrosis
Beger, H. G., Bittner, R., Block, S., & Büchler, M. W. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90579-2 · Cited by 925
Guadalupe, M., Reay, E., Sankaran, S., Prindiville, T., Flamm, J., McNeil, A., & Dandekar, S. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11708-11717.2003 · Cited by 866
Requirement of Interleukin‐17A for Systemic Anti– Candida albicans Host Defense in Mice
Huang, W., Na, L., Fidel, P. L., & Schwarzenberger, P. (2004) · The Journal of Infectious Diseases · doi:10.1086/422329 · Cited by 859
Hunt, P. W., Martin, J. N., Sinclair, E., Bredt, B. M., Hagos, E., Lampiris, H. W., & Deeks, S. G. (2003) · The Journal of Infectious Diseases · doi:10.1086/374786 · Cited by 852
Yang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M. G., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 818
Louis, P., Young, P., Holtrop, G., & Flint, H. J. (2009) · Environmental Microbiology · doi:10.1111/j.1462-2920.2009.02066.x · Cited by 804 · cited 2×
“Indeed, only certain species of the microbiota, predominantly those belonging to a small subset of the Firmicutes, can metabolize complex carbohydrates into short-chain fatty acids (butyrate in particular) that can serve as growth factors for enterocytes (7).”
BackgroundDeeks, S. G., Ramirez, C. M., Liu, L., Guo, H., Gascon, R., Narváez, A. B., Hunt, P. W., Martin, J. N., Kahn, J. S., Levy, J. A., et al. (2004) · Blood · doi:10.1182/blood-2003-09-3333 · Cited by 803
Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22
Takatori, H., Kanno, Y., Watford, W. T., Tato, C. M., Weiss, G. E., Ivanov, I. I., Littman, D. R., & O’Shea, J. J. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072713 · Cited by 769 · cited 1×
“IL-22 is clearly of lymphocyte origin with specific subsets of T cells (especially CD4 T cells) and iLCs capable of its production (92).”
BackgroundIncreased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives
Hollander, D., Vadheim, C. M., Brettholz, E., Petersen, G. M., Delahunty, T., & Rotter, J. I. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-6-883 · Cited by 762 · cited 1×
“That individuals with IBD have significantly higher intestinal permeability compared with healthy controls suggests that one of the mechanisms underlying disease pathogenesis in IBD is damage to the structural barrier of the GI tract (107).”
BackgroundA protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis
Bibiloni, R., Fedorak, R. N., Tannock, G. W., Madsen, K. L., Gionchetti, P., Campieri, M., Simone, C. D., & Sartor, R. B. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41794.x · Cited by 743
Walker, A. W., Sanderson, J. D., Churcher, C. M., Parkes, G. C., Hudspith, B. N., Rayment, N. B., Brostoff, J., Parkhill, J., Dougan, G., & Petrovska, L. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-7 · Cited by 727 · cited 13×
“Inflammatory Bowel Disease MT has been most widely recognized as playing a major role in the pathogenesis of IBD.”
BackgroundResultInfluentialWisse, E., Zanger, R. D., Charels, K., Smissen, P. V. D., & McCuskey, R. S. (1985) · Hepatology · doi:10.1002/hep.1840050427 · Cited by 712
Beignon, A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26032 · Cited by 674
Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections
Brenchley, J. M., Paiardini, M., Knox, K. S., Asher, A. I., Cervasi, B., Asher, T. E., Scheinberg, P., Price, D. A., Hage, C. A., Kholi, L. M., et al. (2008) · Blood · doi:10.1182/blood-2008-05-159301 · Cited by 670
Self-citationRadaeva, S., Sun, R., Pan, H., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 638
Hunt, P. W., Brenchley, J. M., Sinclair, E., McCune, J. M., Roland, M. E., Page, K. A., Hsue, P. Y., Emu, B., Krone, M., Lampiris, H. W., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/524143 · Cited by 634
Self-citationThe structure and function of human IgA
Kerr, M. A. (1990) · Biochemical Journal · doi:10.1042/bj2710285 · Cited by 599 · cited 6×
“Indeed, individuals with IgA deficiency tend to mount large systemic IgG and IgM antibody responses to GI tract luminal antigens, including food and bacteria (60).”
BackgroundInfluentialJiang, W., Lederman, M. M., Hunt, P. W., Sieg, S. F., Haley, K. P., Rodriguez, B. A., LANDAY, A. L., Martin, J. N., Sinclair, E., Asher, A. I., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/597476 · Cited by 598
Self-citationSex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1
Meier, A., Chang, J. J., Chan, E. S., Pollard, R. B., Sidhu, H. K., Kulkarni, S., Wen, F., Lindsay, R. J., Orellana, L., Mildvan, D., et al. (2009) · Nature Medicine · doi:10.1038/nm.2004 · Cited by 596
Sawa, S., Lochner, M., Satoh‐Takayama, N., Dulauroy, S., Berard, M., Kleinschek, M. A., Cua, D., Santo, J. P. D., & Eberl, G. (2011) · Nature Immunology · doi:10.1038/ni.2002 · Cited by 596
CD4+ Lymphoid Tissue-Inducer Cells Promote Innate Immunity in the Gut
Sonnenberg, G. F., Monticelli, L. A., Elloso, M. M., Fouser, L. A., & Artis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.12.009 · Cited by 591
Critical Roles of Activation-Induced Cytidine Deaminase in the Homeostasis of Gut Flora
Fagarasan, S., Muramatsu, M., Suzuki, K., Nagaoka, H., Hiai, H., & Honjo, T. (2002) · Science · doi:10.1126/science.1077336 · Cited by 590
Enteropathy Associated with the Acquired Immunodeficiency Syndrome
Kotler, D. P., GAETZ, H. P., LANGE, M., KLEIN, E. B., & HOLT, P. R. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-4-421 · Cited by 590
Yel, L. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9357-x · Cited by 582
HIV disease: fallout from a mucosal catastrophe?
Brenchley, J. M., Price, D. A., & Douek, D. C. (2006) · Nature Immunology · doi:10.1038/ni1316 · Cited by 579
Self-citationFallani, M., Young, D., Scott, J. A., Norin, E. L., Amarri, S., Adam, R., Aguilera, J., Khanna, S., Gil, Á., Edwards, C. A., et al. (2010) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181d1b11e · Cited by 559 · cited 1×
“Indeed, among infants, factors such as geographical location, breast-feeding, mode of delivery, and antibiotic use can clearly alter the composition of the microbiota (26).”
BackgroundC-Reactive Protein as a Marker for Inflammatory Bowel Disease
Vermeire, S., Assche, G. V., & Rutgeerts, P. J. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200409000-00026 · Cited by 534
Bode, C., Kugler, V., & Bode, J. C. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80003-x · Cited by 529
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells
Prasad, S. B., Mingrino, R., Kaukinen, K., Hayes, K. L., Powell, R. M., MacDonald, T. T., & Collins, J. E. (2005) · Laboratory Investigation · doi:10.1038/labinvest.3700316 · Cited by 514 · cited 2×
“Moreover, inflammatory conditions can be associated with upregulation of specific channel-forming claudins such as claudin 2 (66, 68).”
BackgroundReid, G., Charbonneau, D., Erb, J., Kochanowski, B., Beuerman, D., Poehner, R., & Bruce, A. W. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(02)00465-0 · Cited by 514
Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., & Tandon, R. K. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.07.016 · Cited by 513
Ancuta, P., Kamat, A., Kunstman, K. J., Kim, E.-Y., Autissier, P., Wurcel, A., Zaman, T., Stone, D., Mefford, M., Morgello, S., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002516 · Cited by 499
Estes, J. D., Harris, L. D., Klatt, N. R., Tabb, B., Pittaluga, S., Paiardini, M., Barclay, G. R., Smedley, J. V., Pung, R., Oliveira, K. M., et al. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001052 · Cited by 498
Self-citationEfficacy of Lactobacillus GG in maintaining remission of ulcerative colitis
Zocco, M. A., Verme, L. Z. D., Cremonini, F., Piscaglia, A. C., Nista, E. C., Candelli, M., Novi, M., Rigante, D., Cazzato, I. A., Ojetti, V., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02927.x · Cited by 472
Elson, C. O., Cong, Y., McCracken, V. J., Dimmitt, R. A., Lorenz, R. G., & Weaver, C. T. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00291.x · Cited by 469 · cited 1×
“Additionally, altered composition of the GI tract microbiota has also been suggested to play a role in IBD pathogenesis (99, 100), as revealed by mouse models of IBD in which inflammation is significantly reduced when the mice are housed in germ-free conditions (101, 102).”
BackgroundKirpich, I., Solovieva, N., Leikhter, S., Shidakova, N. A., Lebedeva, O. V., Sidorov, P., Bazhukova, T. A., Soloviev, A., Barve, S., McClain, C., et al. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.08.006 · Cited by 464
Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90933-3 · Cited by 461
The role of the gut microbiota in nonalcoholic fatty liver disease
Abu-Shanab, A., & Quigley, E. M. M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.172 · Cited by 457
The role of the intestinal microbiota in the development of atopic disorders
Penders, J., Stobberingh, E. E., van den Brandt, P. A., & Thijs, C. T. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01462.x · Cited by 447
Koteish, A. A., & Diehl, A. M. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12932 · Cited by 447
THE LEAKY GUT OF ALCOHOLISM: POSSIBLE ROUTE OF ENTRY FOR TOXIC COMPOUNDS
Bjarnason, I., Ward, K., & Peters, T. B. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92109-3 · Cited by 432
Storb, R. F., Prentice, R. L., Buckner, C. D., Clift, R. A., Appelbaum, F. R., Deeg, J., Doney, K., Hansen, J. A., Mason, M. W., Sanders, J. E., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198302103080602 · Cited by 431
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
Bažil, V., & Strominger, J. L. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1567 · Cited by 430 · cited 1×
“Following LPS stimulation, CD14+ monocytes/macrophages secrete sCD14 and shed surface CD14, which binds to LPS (49, 50).”
BackgroundGupta, P., Andrew, H., Kirschner, B. S., & Guandalini, S. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200010000-00024 · Cited by 429
Lumsden, A. B., Henderson, M. J., & Kutner, M. H. (1988) · Hepatology · doi:10.1002/hep.1840080207 · Cited by 427 · cited 1×
“Indeed, concentrations of LPS in the portal vein are higher than in either the hepatic or peripheral veins (40), and bacteria can be cultured from healthy liver explants (41).”
BackgroundKao, C.-Y., Chen, Y., Thai, P., Wachi, S., Huang, F., Kim, C., Harper, R. W., & Wu, R. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.3482 · Cited by 424
Lee, S. H., Starkey, P. M., & Gordon, S. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.3.475 · Cited by 423 · cited 1×
“The GI tract is a major reservoir of macrophages in the body (37) and have a very distinct phenotype and functional capacity.”
BackgroundClayburgh, D. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24970 · Cited by 419 · cited 2×
“TNF stimulation of enterocytes also leads to phosphorylation of the myosin light chain by myosin light chain kinase (MLCK) (73), which in turn leads to intestinal permeability via cytoskeleton rearrangement and modulation of tight junction protein expression.”
BackgroundJohansen, F., Pekna, M., Norderhaug, I. N., Haneberg, B., Hietala, M. A., Krajči, P., Betsholtz, C., & Brandtzæg, P. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.915 · Cited by 417 · cited 1×
“Secretory IgA thus serves as a line of defense against MT by limiting adhesion and entry into the epithelium, thereby facilitating clearance via the fecal stream (13, 14).”
BackgroundFavre, D., Lederer, S., Kanwar, B., Ma, Z.-M., Proll, S. C., Kasakow, Z., Mold, J. E., Swainson, L. A., Barbour, J. D., Baskin, C. R., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000295 · Cited by 415
Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge
Knöll, P., Schlaak, J., Uhrig, A., Kempf, P., Büschenfelde, K. M. Z., & Gerken, G. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80433-1 · Cited by 403
Tight junctions as targets of infectious agents
Guttman, J. A., & Finlay, B. B. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.10.028 · Cited by 398 · cited 1×
“Rotavirus, reovirus, norovirus, adenovirus, and coxsackievirus infections are all associated with disruption of the structural barrier of the GI tract and subsequent increased MT (64, 65).”
BackgroundPathogenesis and immune mechanisms of chronic inflammatory bowel diseases.
Sartor, R. B. (1997) · PubMed · Cited by 391
Zolotarevsky, Y., Hecht, G. A., Koutsouris, A., Gonzalez, D. E., Quan, C., Tom, J., Mrsny, R. J., & Turner, J. R. (2002) · Gastroenterology · doi:10.1053/gast.2002.34235 · Cited by 385 · cited 1×
“Consistent with this observation, inhibition of MLCK restores barrier function after TNF treatment and suggests that therapeutic interventions aimed at decreasing MLCK activity may be a promising approach in the treatment of TNF-mediated dysfunction of the structural barrier, as discussed below (74).”
MethodEffect of alcohol consumption on the gut.
Bode, C., & Christian Bode, J. (2003) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/s1521-6918(03)00034-9 · Cited by 379
Ammori, B., Leeder, P., King, R., Barclay, G., Martin, I., Larvin, M., & Mcmahon, M. (1999) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(99)80067-5 · Cited by 346
Umesaki, Y., Okada, Y., Matsumoto, S., Imaoka, A., & Setoyama, H. (1995) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1995.tb02242.x · Cited by 346
LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
Lamping, N., Dettmer, R., Schröder, N. W. J., Pfeil, D., Hallatschek, W., Burger, R., & Schumann, R. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2338 · Cited by 345 · cited 1×
“However, therapeutically increased levels of circulating LBP can be protective against gram-negative septicemia (54).”
BackgroundRegional specialization in the mucosal immune system: what happens in the microcompartments?
Brandtzæg, P., Bækkevold, E. S., Farstad, I. N., Jahnsen, F. L., Johansen, F., Nilsen, E. M., & Yamanaka, T. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01413-3 · Cited by 342 · cited 23×
“Defense Against MT in the Systemic Circulation As discussed above, in order to access the systemic circulation, microbial antigens that originate in the GI tract must pass through the luminal mucus and IgA, traverse the tight epithelial barrier, escape uptake by GI tract lamina propria macrophages, and then avoid live…”
BackgroundInfluentialTeitelbaum, D. H., & Coran, A. G. (2006) · CRC Press eBooks · doi:10.1201/b13237-67 · Cited by 341
Cooke, K. R., Hill, G. R., Crawford, J. M., Bungard, D., Brinson, Y. S., Delmonte, J., & Ferrara, J. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4285 · Cited by 336
Petrof, E. O., Kojima, K., Ropeleski, M. J., Musch, M. W., Tao, Y., Simone, C. D., & Chang, E. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.001 · Cited by 330
De Palma, G., Nadal, I., Medina, M., Donat, E., Ribes-Koninckx, C., Calabuig, M., & Sanz, Y. (2010) · BMC Microbiology · doi:10.1186/1471-2180-10-63 · Cited by 330 · cited 1×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundSmith, P. D., Smythies, L. E., Mosteller‐Barnum, M., Sibley, D. A., Russell, M. W., Merger, M., Sellers, M. T., Orenstein, J. M., Shimada, T., Graham, M. F., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2651 · Cited by 327
Hubacek, J. A., Pitha, J. V., Škodová, Z., Stanĕk, V., & Poledne, R. (1999) · Circulation · doi:10.1161/01.cir.99.25.3218 · Cited by 327
The host–microbe interface within the gut
Shanahan, F. (2002) · Best Practice & Research Clinical Gastroenterology · doi:10.1053/bega.2002.0342 · Cited by 308
Sandler, N. G., Koh, C., Roque, A., Eccleston, J. L., Siegel, R. B., Demino, M., Kleiner, D. E., Deeks, S. G., Liang, T. J., Heller, T., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.063 · Cited by 307
Self-citationJejunal microflora in patients with chronic alcohol abuse.
Jc, B., Bode, C., Heidelbach, R., Hk, D., & Ga, M. (1984) · PubMed · Cited by 303
Marchetti, G. C., Bellistrì, G. M., Borghi, E., Tincati, C., Ferramosca, S., Francesca, M. L., Morace, G., Gori, A., & Monforte, A. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283112d29 · Cited by 296
Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection
Mehandru, S., Poles, M. A., Tenner‐Racz, K., Jean-Pierre, P., Manuelli, V., Lopez, P., Shet, A., Low, A., Mohri, H., Boden, D., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030484 · Cited by 287
Vereecke, L., Sze, M., Guire, C. M., Rogiers, B., Chu, Y., Schmidt‐Supprian, M., Pasparakis, M., Beyaert, R., & Loo, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092474 · Cited by 283 · cited 2×
“Moreover, tissue-specific disruption of A20 expression within GI tract enterocytes renders them exquisitely sensitive to TNF-induced toxicity and experimental colitis (75).”
BackgroundHuman Immunodeficiency Virus-Related Microbial Translocation and Progression of Hepatitis C
Balagopal, A., Philp, F. H., Astemborski, J. A., Block, T. M., Mehta, A. S., Long, R. E., Kirk, G. D., Mehta, S. H., Cox, A. L., Thomas, D. L., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.022 · Cited by 282
Lochner, M., Ohnmacht, C., Presley, L. L., Bruhns, P., Si‐Tahar, M., Sawa, S., & Eberl, G. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100052 · Cited by 274 · cited 2×
“In these mice, containment of the luminal microbiota requires the generation of abnormally large numbers of tertiary lymphoid tissues (86).”
BackgroundPaneth cell differentiation in the developing intestine of normal and transgenic mice.
Bry, L., Falk, P., Huttner, K. M., Ouellette, A. J., Midtvedt, T., & Gordon, J. I. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10335 · Cited by 273 · cited 1×
“There are four major types of GI tract epithelial cells (32): absorptive enterocytes; mucin-producing goblet cells; enteroendocrine cells, which produce peptide hormones (33); and Paneth cells, which secrete antimicrobial defensins, digestive enzymes, and growth factors (34).”
BackgroundGuerra-Ruiz, A. R., Casafont, F., Crespo, J., Cayón, A., Mayorga, M. M., Estébanez, Á., Fernández-Escalante, J. C., & Pons‐Romero, F. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9243-7 · Cited by 268
Modulatory effects of sCD14 and LBP on LPS-host cell interactions
Kitchens, R. L., & Thompson, P. A. (2005) · Journal of Endotoxin Research · doi:10.1179/096805105x46565 · Cited by 268
Differentiation and self-renewal in the mouse gastrointestinal epithelium
Gordon, J. I., & Hermiston, M. L. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90047-7 · Cited by 258 · cited 1×
“Enterocytes are short-lived cells, and the entire mouse GI epithelium is renewed every 3–4 days (35).”
BackgroundArnsten, J. H., Freeman, R., Howard, A. A., Floris-Moore, M., Lo, Y., & Klein, R. S. (2007) · AIDS · doi:10.1097/qad.0b013e3280148c05 · Cited by 252
Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease
Schreiber, S., Nikolaus, S., Hampe, J., Hämling, J., Koop, I., Groessner, B., Lochs, H., & Raedler, A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)03339-x · Cited by 252
Guadalupe, M., Sankaran, S., George, M. D., Reay, E., Verhoeven, D. E., Shacklett, B. L., Flamm, J., Wegelin, J. A., Prindiville, T. P., & Dandekar, S. (2006) · Journal of Virology · doi:10.1128/jvi.00120-06 · Cited by 248
Caradonna, L., Amati, L., Magrone, T., Pellegrino, N. M., Jirillo, E., & Caccavo, D. (2000) · Journal of Endotoxin Research · doi:10.1177/09680519000060030101 · Cited by 247
CD4+ T Cells Mediate Abscess Formation in Intra-abdominal Sepsis by an IL-17-Dependent Mechanism
Chung, D. R., Kasper, D. L., Panzo, R. J., Chtinis, T., Grusby, M. J., Sayegh, M. H., & Tzianabos, A. O. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1958 · Cited by 246
Giorgi, J. V., Lyles, R. H., Matud, J. L., Yamashita, T. E., Mellors, J. W., Hultin, L. E., Jamieson, B. D., Margolick, J. B., Rinaldo, C. R., Phair, J., et al. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200204010-00004 · Cited by 246
Cecchinato, V., Trindade, C. J., Laurence, A. D. J., Héraud, J., Brenchley, J. M., Ferrari, M. G., Zaffiri, L., Tryniszewska, E. A., Tsai, W. P., Vaccari, M., et al. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.14 · Cited by 244
Self-citationGori, A., Tincati, C., Rizzardini, G., Torti, C., Quirino, T., Haarman, M., Amor, K. B., van Schaik, J., Vriesema, A. J. M., Knol, J., et al. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.01729-07 · Cited by 232 · cited 1×
“Comparative studies of culturable microbiota in human immunodeficiency virus (HIV)-infected and uninfected individuals have shown significant differences between the two, suggesting that the altered microbiota may contribute to HIV disease progression (27).”
BackgroundModulatory effects of sCD14 and LBP on LPS-host cell interactions
Kitchens, R. L., & Thompson, P. A. (2005) · Journal of Endotoxin Research · doi:10.1177/09680519050110040701 · Cited by 231 · cited 4×
“sCD14 and LBP both bind LPS and can, at given relative concentrations to one another and LPS, transfer LPS either to high-density lipoproteins (HDLs) to decrease the bioactivity of LPS or to the TLR4/MD-2/CD14 complex on monocytes/macrophages, leading to LPS-mediated stimulation (50).”
BackgroundInfluentialSerum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease
Pastor, Ó., López–Sanromán, A., Albéniz, E., Martínez, A. D. L. H., Sevillano, E. R., & Albillos, A. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20019 · Cited by 229 · cited 10×
“In healthy humans these proteins circulate at high concentrations in plasma, reaching the milligram/ liter levels (50, 52). sCD14 and LBP both bind LPS and can, at given relative concentrations to one another and LPS, transfer LPS either to high-density lipoproteins (HDLs) to decrease the bioactivity of LPS or to the…”
BackgroundInfluentialSignificance of systemic endotoxaemia in inflammatory bowel disease.
Gardiner, K. R., HALLIDAY, M. I., Barclay, G. R., Milne, L., Brown, D. J., Stephens, S., Maxwell, R., & Rowlands, B. J. (1995) · Gut · doi:10.1136/gut.36.6.897 · Cited by 226 · cited 7×
“Indeed, during the acute phase of infection EndoCAb titers decrease, sCD14 levels increase, and most microbial products found within the lamina propria of the GI tract are within the specialized tissue macrophages described above (52, 126, 139).”
BackgroundInfluentialIntestinal macrophages: unique effector cells of the innate immune system
Smith, P. D., Ochsenbauer‐Jambor, C., & Smythies, L. E. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00288.x · Cited by 225 · cited 1×
“Should microbial products traverse the mucus and epithelial barriers, they are met by a large number of specialized resident macrophages that prevent such products from accessing the systemic circulation (36).”
BackgroundBrubaker, P. L., & Anini, Y. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-107 · Cited by 223
Cassol, E., Malfeld, S., Mahasha, P. W., der Merwe, V., Cassol, S. A., Seebregts, C. J., Alfano, M., Poli, G., & Rossouw, T. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/655229 · Cited by 218
Dietary Composition and Nonalcoholic Fatty Liver Disease
Solga, S. F., Alkhuraishe, A. R., Clark, J. M., TORBENSON, M., Greenwald, A., Diehl, A. M., & Magnuson, T. H. (2004) · Digestive Diseases and Sciences · doi:10.1023/b:ddas.0000043367.69470.b7 · Cited by 214
Role of the faecal stream in the maintenance of Crohn's colitis.
Harper, P. H., Lee, E. C., Kettlewell, M. G. W., Bennett, M. K., & Jewell, D. P. (1985) · Gut · doi:10.1136/gut.26.3.279 · Cited by 202 · cited 1×
“Additionally, altered composition of the GI tract microbiota has also been suggested to play a role in IBD pathogenesis (99, 100), as revealed by mouse models of IBD in which inflammation is significantly reduced when the mice are housed in germ-free conditions (101, 102).”
BackgroundHopkins, A. M., Walsh, S. V., Verkade, P., Boquet, P., & Nusrat, A. (2003) · Journal of Cell Science · doi:10.1242/jcs.00300 · Cited by 202
Wu, Z., Nybom, P., & Magnusson, K.-E. (2000) · Cellular Microbiology · doi:10.1046/j.1462-5822.2000.00025.x · Cited by 195
Macal, M., Sankaran, S., Chun, T.-W., Reay, E., Flamm, J., Prindiville, T., & Dandekar, S. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.35 · Cited by 195
Modulation of tight junction structure and function by cytokines
Walsh, S. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00048-x · Cited by 188 · cited 1×
“Indeed, it has been suggested that the ability of inflammatory cytokines to increase paracellular permeability allows neutrophil migration across epithelial barriers to combat invasive pathogens directly (69).”
BackgroundBiostructure of Fecal Microbiota in Healthy Subjects and Patients With Chronic Idiopathic Diarrhea
Swidsinski, A., Loening–Baucke, V., Verstraelen, H., Osowska, S., & Doerffel, Y. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.04.017 · Cited by 178
Structural and functional changes of the duodenum in human norovirus infection
Troeger, H., Loddenkemper, C., Schneider, T., Schreier, E., Epple, H.-J., Zeitz, M., Fromm, M., & Schulzke, J.-D. (2008) · Gut · doi:10.1136/gut.2008.160150 · Cited by 175 · cited 1×
“Rotavirus, reovirus, norovirus, adenovirus, and coxsackievirus infections are all associated with disruption of the structural barrier of the GI tract and subsequent increased MT (64, 65).”
BackgroundPrantera, C., Lochs, H. H., Campieri, M., Scribano, M. L., Sturniolo, G. C., CASTIGLIONE, F., & Cottone, M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02879.x · Cited by 163
Gut-liver axis: a new point of attack to treat chronic liver damage?
Loguercio, C., Simone, T. D., Federico, A. D., Terracciano, F., Tuccillo, C., CHICCO, M. D., Cartenı̀, M., & Blanco, C. D. V. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05942.x · Cited by 155
Sharpstone, D., Neild, P., Crane, R., Taylor, C. M., Hodgson, C., Sherwood, R., Gazzard, B., & Bjarnason, I. (1999) · Gut · doi:10.1136/gut.45.1.70 · Cited by 155
Matot, I., & Sprung, C. L. (2001) · Intensive Care Medicine · doi:10.1007/pl00003795 · Cited by 153 · cited 1×
“In extreme cases of MT, septic shock ensues, where patient mortality can approach 70% (29) and is characterized by clinical manifestations including thermal dysregulation (hypothermia or hyperthermia), tachycardia, tachypnea, and altered white blood cell count (leukocytopenia or leukocytosis).”
BackgroundGionchetti, P., Rizzello, F., Ferrieri, A., Venturi, A., Brignola, C., Ferretti, M., Peruzzo, S., Miglioli, M., & Campieri, M. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026648812439 · Cited by 150
Loeffler, M., Birke, A., Winton, D. J., & Potten, C. S. (1993) · Journal of Theoretical Biology · doi:10.1006/jtbi.1993.1031 · Cited by 149 · cited 1×
“There are four major types of GI tract epithelial cells (32): absorptive enterocytes; mucin-producing goblet cells; enteroendocrine cells, which produce peptide hormones (33); and Paneth cells, which secrete antimicrobial defensins, digestive enzymes, and growth factors (34).”
BackgroundIrvine, S. L., Hummelen, R., Hekmat, S., Looman, C. W. N., Habbema, J. D. F., & Reid, G. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181d8fba8 · Cited by 148
Suzuki, M., Pritchard, D. K., Becker, L., Hoofnagle, A. N., Tanimura, N., Bammler, T. K., Beyer, R. P., Bumgarner, R. E., Vaisar, T., de Beer, M. C., et al. (2010) · Circulation · doi:10.1161/circulationaha.110.961193 · Cited by 145
Buchman, A. L., Katz, S., Fang, J. C., Bernstein, C. N., & Abou‐Assi, S. G. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21117 · Cited by 145
Cutting Edge: Human Th17 Cells Are Identified as Bearing CCR2+CCR5− Phenotype
Sato, W., Aranami, T., & Yamamura, T. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7525 · Cited by 140
IgA deficiency: clinical correlates and responses to pneumococcal vaccine
Edwards, E., Razvi, S., & Cunningham‐Rundles, C. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.12.005 · Cited by 139 · cited 2×
“Giardiasis, mal-absorption, lactose intolerance, celiac disease, ulcerative colitis (UC), nodular lymphoid hyperplasia, and increased epithelial cell proliferation are among the associated diseases (57, 58).”
BackgroundKandori, H., Hirayama, K., TAKEDA, M., & Doi, K. (1996) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.45.155 · Cited by 138 · cited 1×
“Indeed, the absence of the intestinal microbiota in germ-free mice is associated with a decrease in goblet cells, which are also smaller in size, and the thickness of the mucus layer is decreased (10).”
BackgroundPrevalence and Diagnosis of Celiac Disease in IgA-Deficient Children
Meini, A., Pillan, M. N., Ugazio, A. G., Villanacci, V., Monafò, V., & Plebani, A. (1996) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63329-7 · Cited by 135 · cited 1×
“Giardiasis, mal-absorption, lactose intolerance, celiac disease, ulcerative colitis (UC), nodular lymphoid hyperplasia, and increased epithelial cell proliferation are among the associated diseases (57, 58).”
BackgroundEnomoto, N., Yamashina, S., Kono, H., Schemmer, P., Rivera, C. A., Enomoto, A., Nishiura, T., Nishimura, T., Brenner, D. A., & Thurman, R. G. (1999) · Hepatology · doi:10.1002/hep.510290633 · Cited by 132
Li, Q., Estes, J. D., Duan, L., Jessurun, J., Pambuccian, S. E., Forster, C. L., Wietgrefe, S. W., Zupancic, M., Schacker, T. W., Reilly, C., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/525046 · Cited by 131
Massanella, M., Negredo, E., Pérez‐Álvarez, N., Puig, J., Ruiz‐Hernandez, R., Bofill, M., Clotet, B., & Blanco, J. (2010) · AIDS · doi:10.1097/qad.0b013e328337b957 · Cited by 131
Fedwick, J. P., Lapointe, T. K., Meddings, J. B., Sherman, P. M., & Buret, A. G. (2005) · Infection and Immunity · doi:10.1128/iai.73.12.7844-7852.2005 · Cited by 129
Beelen, D., Haralambie, E., Brandt, H., Linzenmeier, G., Muller, K., Quabeck, K., Sayer, H., Graeven, U., Mahmoud, H., & Schaefer, U. (1992) · Blood · doi:10.1182/blood.v80.10.2668.2668 · Cited by 128
Utilization of the Intestinal Tract as a Delivery System for Urogenital Probiotics
Morelli, L., Zonenenschain, D., Piano, M. D., & Cognein, P. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000128938.32835.98 · Cited by 126
In Vitro Binding of Potent Mutagenic Pyrolyzates to Intestinal Bacteria
Morotomi, M., & Mutal, M. (1986) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/77.1.195 · Cited by 123
IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues
Gurney, A. L. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.01.016 · Cited by 120 · cited 1×
“IL-22 belongs to the IL-10 family of cytokines (88), and its receptor is expressed on various epithelial tissues (89) and is believed to mediate epithelial innate immunity (90).”
BackgroundCaradonna, L., Amati, L., Magrone, T., Pellegrino, N. M., Jirillo, E., & Caccavo, D. (2000) · Journal of Endotoxin Research · doi:10.1179/096805100101532063 · Cited by 120
Gore, C., Munro, K., Lay, C., Bibiloni, R., Morris, J., Woodcock, A. A., Čustović, A., & Tannock, G. W. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.061 · Cited by 116 · cited 1×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundRoth, K. A., Hertz, J., & Gordon, J. I. (1990) · The Journal of Cell Biology · doi:10.1083/jcb.110.5.1791 · Cited by 116 · cited 1×
“There are four major types of GI tract epithelial cells (32): absorptive enterocytes; mucin-producing goblet cells; enteroendocrine cells, which produce peptide hormones (33); and Paneth cells, which secrete antimicrobial defensins, digestive enzymes, and growth factors (34).”
BackgroundThe association of giardiasis with reduced intestinal secretory immunoglobulin A
Zinneman, H. H., & Kaplan, A. P. (1972) · Digestive Diseases and Sciences · doi:10.1007/bf02231148 · Cited by 115 · cited 1×
“Because the protective barrier of the GI system is impaired in IgA deficiency, protozoa such as Giardia lamblia can adhere to the epithelium, proliferate, and more easily cause infection (59).”
BackgroundMicrobial Translocation Correlates with the Severity of Both HIV‐1 and HIV‐2 Infections
Nowroozalizadeh, S., Månsson, F., da Silva, Z. J., Repits, J., Dabo, B., Pereira, C. C., Biague, A. J., Albert, J., Nielsen, J. O., Aaby, P., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651430 · Cited by 115
Obermeier, F., Dunger, N., Strauch, U., Hofmann, C., Bleich, A., Grunwald, N., Hedrich, H. J., Aschenbrenner, E., Schlegelberger, B., Rogler, G., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.061 · Cited by 112 · cited 1×
“Additionally, altered composition of the GI tract microbiota has also been suggested to play a role in IBD pathogenesis (99, 100), as revealed by mouse models of IBD in which inflammation is significantly reduced when the mice are housed in germ-free conditions (101, 102).”
BackgroundPappo, I., Becovier, H., Berry, E. M., & Freund, H. R. (1991) · Journal of Surgical Research · doi:10.1016/0022-4804(91)90078-z · Cited by 111
Lorenz, E., Schwartz, D. A., Martin, P. J., Gooley, T. A., Lin, M.-T., Chien, J. W., Hansen, J. A., & Clark, J. G. (2001) · Transplantation and Cellular Therapy · doi:10.1053/bbmt.2001.v7.pm11529488 · Cited by 109
The Microbiota and Allergies/Asthma
Huffnagle, G. B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000549 · Cited by 108 · cited 1×
“Previous studies have implicated an altered balance in the composition of the microbiota (dysbiosis) in many diseases, such as obesity (16, 17), celiac disease (18), type 2 diabetes (19), atopic eczema (20, 21), asthma (22), inflammatory bowel disease (IBD) (23, 24), and chronic diarrhea (25).”
BackgroundTumor necrosis factor: immunologic, antitumor, metabolic, and cardiovascular activities.
Grünfeld, C., & Palladino, M. A. (1990) · PubMed · Cited by 106
Cooke, K. R., Olkiewicz, K. M., Erickson, N. T., & Ferrara, J. L. M. (2002) · Journal of Endotoxin Research · doi:10.1177/09680519020080061301 · Cited by 101
Schäfer, C. (2002) · Alcohol and Alcoholism · doi:10.1093/alcalc/37.1.81 · Cited by 99
Role of endotoxin in the hypermetabolic state after acute ethanol exposure
Rivera, C. A., Bradford, B. U., Seabra, V., & Thurman, R. G. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.6.g1252 · Cited by 99
Ruemmele, F. M., Beaulieu, J., Dionne, S., Levy, E. H., Seidman, E. G., Cerf–Bensussan, N., & Lentze, M. J. (2002) · Gut · doi:10.1136/gut.51.6.842 · Cited by 97
Hypoxia. Regulation of NFκB signalling during inflammation: the role of hydroxylases
Oliver, K. M., Taylor, C. T., & Cummins, E. P. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2575 · Cited by 92
Pasternak, B. A., D’Mello, S., Jurickova, I., Han, X., Willson, T. A., Flick, L. M., Petiniot, L. K., Uozumi, N., Divanovic, S., Trauernicht, A. K., et al. (2009) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21132 · Cited by 91 · cited 15×
“In healthy humans these proteins circulate at high concentrations in plasma, reaching the milligram/ liter levels (50, 52). sCD14 and LBP both bind LPS and can, at given relative concentrations to one another and LPS, transfer LPS either to high-density lipoproteins (HDLs) to decrease the bioactivity of LPS or to the…”
BackgroundInfluentialBarclay, G. R. (1995) · PubMed · Cited by 90
Lakatos, P. L., Kiss, L. S., Palatka, K., Altorjay, I., Antal‐Szalmás, P., Pályu, E., Udvardy, M., Molnár, T., Farkas, K., Veres, G., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21402 · Cited by 86
Nigam, P., Kwa, S., Velu, V., & Amara, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002807 · Cited by 81
McCutchan, J. A., Wu, J. W., Robertson, K., Koletar, S. L., Ellis, R. J., Cohn, S. E., Taylor, M. J., Woods, S. P., Heaton, R. K., Currier, J. S., et al. (2007) · AIDS · doi:10.1097/qad.0b013e3280ef6acd · Cited by 81
Ammori, B. J., Fitzgerald, P., Hawkey, P. M., & McMahon, M. J. (2003) · Pancreas · doi:10.1097/00006676-200301000-00004 · Cited by 79
Pérez‐Bosque, A., Miró, L., Polo, J., Russell, L., Campbell, J. M., Weaver, E. M., Crenshaw, J., & Moretó, M. (2009) · Journal of Nutrition · doi:10.3945/jn.109.112466 · Cited by 75
Caradonna, L., Amati, L., Lella, P., Jirillo, E., & Caccavo, D. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.02085.x · Cited by 72 · cited 1×
“In individuals with active disease, high levels of circulating bacterial products are associated with increased levels of proinflammatory cytokines (108, 112–114), and granulocyte phagocytic activity is decreased, presumably due to recent bacterial phagocytosis in vivo (111).”
BackgroundAnselmi, A., Vendrame, D., Rampon, O., Giaquinto, C., Zanchetta, M., & Rossi, A. D. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03526.x · Cited by 72
Natural Human Antibodies to Gram-Negative Bacteria: Immunoglobulins G, A, and M
Cohen, I. R., & Norins, L. C. (1966) · Science · doi:10.1126/science.152.3726.1257 · Cited by 69
Mucosal Bacterial Growth in the Upper Gastrointestinal Tract in Alcoholics (Heavy Drinkers)
Hauge, T., Persson, J., & Danielsson, D. G. (2009) · Digestion · doi:10.1159/000201507 · Cited by 68
Balagopal, A., Ray, S. C., de Oca, R. M., Sutcliffe, C. G., Vivekanandan, P., Higgins, Y., Mehta, S. H., Moore, R. D., Sulkowski, M., Thomas, D. L., et al. (2009) · AIDS · doi:10.1097/qad.0b013e3283324344 · Cited by 67
Biological and Clinical Significance of Endotoxemia in the Course of Hepatitis C Virus Infection
Caradonna, L., Mastronardi, M., Magrone, T., Cozzolongo, R., Cuppone, R., Manghisi, O. G., Caccavo, D., Pellegrino, N. M., Amoroso, A., Jirillo, E., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612024606983 · Cited by 66
Kapembwa, M. S., Fleming, S. C., Sewankambo, N. K., Serwadda, D., Lucas, S. B., Moody, A. H., & Griffin, G. E. (1991) · Clinical Science · doi:10.1042/cs0810327 · Cited by 65
Baroncelli, S., Galluzzo, C. M., Pirillo, M. F., Mancini, M. G., Weimer, L. E., Andreotti, M., Amici, R., Vella, S., Giuliano, M., & Palmisano, L. (2009) · Journal of Clinical Virology · doi:10.1016/j.jcv.2009.09.011 · Cited by 61
Relationship of antibodies to endotoxin core to mortality in medical patients with sepsis syndrome
Strutz, F. M., Heller, G., Krasemann, K., Krone, B., & Muller, G. A. (1999) · Intensive Care Medicine · doi:10.1007/s001340050877 · Cited by 60 · cited 2×
“When microbial products gain access to the circulation, such as during sepsis, these antibodies, termed EndoCAb, bind to and clear LPS from the circulation, and as a result their titers decrease (46).”
BackgroundSystemic toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease
McDonnell, M. E., Liang, Y., Noronha, A. M., Coukos, J. A., Kasper, D. L., Farraye, F. A., & Ganley-Leal, L. M. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21424 · Cited by 60 · cited 13×
“Inflammatory Bowel Disease MT has been most widely recognized as playing a major role in the pathogenesis of IBD.”
BackgroundInfluentialPérez‐Bosque, A., Miró, L., Polo, J., Russell, L., Campbell, J. M., Weaver, E. M., Crenshaw, J., & Moretó, M. (2008) · Journal of Nutrition · doi:10.1093/jn/138.3.533 · Cited by 59
Shnyra, A., & Lindberg, A. A. (1995) · Infection and Immunity · doi:10.1128/iai.63.3.865-873.1995 · Cited by 58 · cited 1×
“Both Kupffer cells and LSECs are responsive to direct stimulation with bacterial products (43), with measurably distinct responses compared with those of other tissue macrophages or monocytes in peripheral blood.”
BackgroundPenalva, J. C., Martínez, J. F., Laveda, R., Esteban, A., Muñoz, C., Sáez, J., Such, J. M., Navarro, S., Feu, F., Sánchez–Payá, J., et al. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000129060.46654.e0 · Cited by 55
Cytokine association with bacterial DNA in serum of patients with inflammatory bowel disease
Gutiérrez, A., Francés, R., Amorós, A., Zapater, P., Garmendia, M., NDongo, M., Caño, R., Jover, R., Such, J. M., & Pérez‐Mateo, M. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20806 · Cited by 55 · cited 7×
“The early increase in intestinal permeability and systemic endotoxin exposure in patients with severe acute pancreatitis is not associated with systemic bacterial translocation: molecular investigation of microbial DNA in the blood.”
BackgroundInfluentialCorl, B. A., Harrell, R. J., Moon, H. K., Phillips, O., Weaver, E. M., Campbell, J. M., Arthington, J. D., & Odle, J. (2007) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.12.011 · Cited by 51
Wöstmann, B. S. J., Pleasants, J. R., Bealmear, P. M., & Kincade, P. W. (1970) · PubMed Central · Cited by 49
Papasavvas, E., Pistilli, M., Reynolds, G., Bucki, R., Azzoni, L., Chehimi, J., Janmey, P. A., DiNubile, M. J., Ondercin, J., Kostman, J. R., et al. (2009) · AIDS · doi:10.1097/qad.0b013e32831e9c76 · Cited by 49
Singh, R., Bullard, J., Kalra, M., Assefa, S., Kaul, A., Vonfeldt, K., Strom, S. C., Conrad, R., Sharp, H. L., & Kaul, R. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.09.006 · Cited by 46
Cooke, K. R., Olkiewicz, K. M., Erickson, N. T., & Ferrara, J. L. M. (2002) · Journal of Endotoxin Research · doi:10.1179/096805102125001046 · Cited by 46
Research works printed but not linked: 10
- Wostmann BS, 1970, Immunology, 19, 443
- Morotomi M, 1986, J. Natl. Cancer Inst., 77, 195
- Lindsey DC, 1991, Circ. Shock, 34, 298
- Barclay GR., 1995, Prog. Clin. Biol. Res., 392, 263
- Tapping RI, 1998, Prog. Clin. Biol. Res., 397, 73
- Grunfeld C, 1990, Adv. Intern. Med., 35, 45
- Sartor RB., 1997, Am. J. Gastroenterol., 92, 5S
- Rivera CA, 1998, Am. J. Physiol., 275, G1252
- Alexander-Williams J, 1976, Proc. R. Soc. Med., 69, 327
- Sugimoto K, 2008, J. Clin. Investig., 118, 534
Cited by
Sorted by citations
Role of the microbiota in immunity and inflammation.
Belkaid, Y., & Hand, T. W. (2014) · Cell · doi:10.1016/j.cell.2014.03.011 · Cited by 5,385
“In a number of models of gastrointestinal infections, such as Toxoplasma gondii and Yersinia pseudotuberculosis, immunopathology can also induce the translocation of commensal bacteria (Brenchley and Douek, 2012; Brenchley et al., 2006; Estes et al., 2010; Hand et al., 2012; Heimesaat et al., 2006; Jung et al., 2012;…”
BackgroundInteractions between the microbiota, immune and nervous systems in health and disease
Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017) · Nature Neuroscience · doi:10.1038/nn.4476 · Cited by 1,900
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
The Human Microbiota in Health and Disease
Wang, B., Yao, M., Lv, L., Ling, Z., & Li, L. (2017) · Engineering · doi:10.1016/j.eng.2017.01.008 · Cited by 916
“Offending pathogens colonize the intestinal mucosa, thus resulting in the induction of a strong inflammatory response, followed by the translocation of the intestinal bacteria [41,42].”
BackgroundNeutrophil ageing is regulated by the microbiome
Zhang, D., Chen, G., Manwani, D., Mortha, A., Xu, C., Faith, J. J., Burk, R. D., Kunisaki, Y., Jang, J.-E., Scheiermann, C., et al. (2015) · Nature · doi:10.1038/nature15367 · Cited by 839
Metadata
- Authors
- Brenchley, J. M., & Douek, D. C.
- Affiliations
- National Institutes of Health (US)
- Venue
- Annual Review of Immunology
- Publisher
- Annual Reviews
- Published
- 2012-04-23
- Volume
- 30
- Issue
- 1
- Pages
- 149-173
- ISSN
- 0732-0582 (ISSN-L)
- 1545-3278
- PMC
- PMC3513328
- OpenAlex
- W2146488133
- Cited by
- 496
- References
- 222
- Citations by year
- 2026: 22 · 2025: 32 · 2024: 42 · 2023: 30 · 2022: 44 · 2021: 33 · 2020: 42 · 2019: 59 · 2018: 24 · 2017: 40 · 2016: 34 · 2015: 20 · 2014: 27 · 2013: 32 · 2012: 15
- FWCI
- 2.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annual Review of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (Z01AI001029, ZIAAI005034)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- microbial translocation, gut microbiota, gastrointestinal tract, host-microbe interactions, immune activation, systemic inflammation, therapeutic interventions
- MeSH terms
- Animals, Anti-Infective Agents, Digestive System Diseases, Humans, Immunologic Factors, Probiotics, Gastrointestinal Tract, Host-Pathogen Interactions, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review